%0 Journal Article %T Marijuana may lead to increased platelet activity in trauma patients. %A Tanner DF %A Eastes JG %A Reeson EA %A Lam EW %A Rahaman CA %A O'Toole DM %A Tolan GC %A Babarinde OA %A Kupanoff KM %A Huang DD %A Jones MD %A Czarkowski BR %A Weinberg JA %A Bogert JN %J Am J Surg %V 0 %N 0 %D 2024 Jul 2 %M 39003092 %F 3.125 %R 10.1016/j.amjsurg.2024.115822 %X BACKGROUND: Delta-9-tetraydrocannabinol (THC) usage is associated with venous thromboembolic events (VTE) in trauma patients. We hypothesized that THC ​+ ​trauma patients would have less platelet inhibition than THC - patients using thromboelastography with platelet mapping (TEG-PM).
METHODS: Results from initial TEG- PM assays and patient's UDS were reviewed between 2019 and 2023. Mean levels of arachidonic acid (AA) and adenosine diphosphate (ADP) percent inhibition were compared by THC status.
RESULTS: 793 patients had TEG-PM and UDS data. Mean levels of arachidonic acid (AA) percentage inhibition were 32.6 ​± ​34.2. AA inhibition was lower for THC ​+ ​vs THC- patients (THC+ 23.9 ​± ​27.0 vs THC- 34.3 ​± ​35.3, P ​< ​0.001). There was no association between THC status and ADP inhibition (THC+ 32.5 ​± ​27.1 vs THC- 30.8 ​± ​28.4, P ​= ​0.536).
CONCLUSIONS: To our knowledge, our data are the first to suggest a clinically measurable increase in platelet reactivity in THC ​+ ​trauma patients. More work is needed to determine if addition of aspirin to the chemoprophylaxis strategy for THC ​+ ​patients would mitigate the known association of THC with VTE.